Anavex Life Sciences Corp (AVXL)

[tootalljones]

What will happen to the price if the company reports on 10 additional patients, who by today, are all completely finished with their phase 2A experience? There is a major conf oct 10 or thereabouts.

Isn't the purpose of Open label to Report to investors and providers how the trial is doing? And what if these 10 are even remotely consistent with the prior 12, which is a logical assumption, what will that do to the share price?

This is going to happen. This is reality approaching soon.

Traders and investors are discouraged by the market's retracement, but what I describe above is going to happen. Worst case scenario, it happens with a much bigger Kaboom higher, in December. In any event, we will get good dope from the company well before then.

Patience, just a tiny bit, will be richly rewarded. Bullish.